Technical Analysis for ORGO - Organogenesis Holdings Inc.

Grade Last Price % Change Price Change
D 2.78 0.36% 0.01
ORGO closed up 0.36 percent on Friday, November 1, 2024, on 36 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: Nov 12
*** please verify all earnings dates ***
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
NR7 Range Contraction 0.00%
Stochastic Reached Oversold Weakness 0.00%
Inside Day Range Contraction 0.00%
Gapped Up Strength 0.00%
Oversold Stochastic Weakness 0.00%
200 DMA Resistance Bearish 0.36%
Fell Below 50 DMA Bearish 0.36%
MACD Bearish Centerline Cross Bearish 0.36%
Lower Bollinger Band Touch Weakness 0.36%
Fell Below 200 DMA Bearish -3.81%

   Recent Intraday Alerts

Alert Time
Gap Up Partially Closed about 20 hours ago
Gapped Up (Partial) about 23 hours ago
Up 2% about 23 hours ago
Up 1% about 23 hours ago
60 Minute Opening Range Breakdown 1 day ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Organogenesis Holdings Inc. Description

Organogenesis Holdings Inc., a regenerative medicine company, focuses on the development, manufacture, and commercialization of solutions for the advanced wound care, and surgical and sports medicine markets primarily in the United States. The company's advanced wound care products include Apligraf for the treatment of venous leg ulcers and diabetic foot ulcers (DFUs); Dermagraft for treating DFUs; PuraPly AM to address biofilm across a range of wound types; and Affinity and NuShield to address various wound sizes and types. Its surgical and sports medicine products comprise ReNu for in-office joint and tendon applications; NuCel for bony fusion in the spine and extremities; NuShield and Affinity for surgical applications in targeted soft tissue repairs; and PuraPly AM for the surgical treatment of open wounds. The company's pipeline products include TransCyte for the treatment of second- and third-degree burns; PuraForce, a bioengineered porcine collagen surgical matrix for use in soft tissue reinforcement applications; Novachor for the treatment of chronic and acute wounds; Gintuit for the treatment of mucogingival conditions in adults; and PuraPly XT and PuraPly MZ for the treatment of chronic and acute wounds, as well as for surgical treatment of open wounds. It serves hospitals, wound care centers, government facilities, ambulatory service centers, and physician offices. The company sells its products through direct sales representatives and independent agencies. Organogenesis Holdings Inc. was founded in 1985 and is headquartered in Canton, Massachusetts.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Medicine Clinical Medicine Organ Systems Surgery Wound Regenerative Medicine Spine Ulcer Acute Pain Burns First Aid Sports Medicine Collagen Medicine Products Surgical Treatment Wound Care Products Surgical Applications Venous Leg Ulcers Venous Ulcer Wound Bed Preparation

Is ORGO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 4.705
52 Week Low 1.96
Average Volume 402,484
200-Day Moving Average 2.90
50-Day Moving Average 2.88
20-Day Moving Average 2.99
10-Day Moving Average 2.91
Average True Range 0.13
RSI (14) 42.86
ADX 17.14
+DI 17.61
-DI 26.57
Chandelier Exit (Long, 3 ATRs) 2.87
Chandelier Exit (Short, 3 ATRs) 3.15
Upper Bollinger Bands 3.26
Lower Bollinger Band 2.72
Percent B (%b) 0.1
BandWidth 18.00
MACD Line -0.02
MACD Signal Line 0.02
MACD Histogram -0.0387
Fundamentals Value
Market Cap 365.05 Million
Num Shares 131 Million
EPS 0.10
Price-to-Earnings (P/E) Ratio 27.80
Price-to-Sales 1.07
Price-to-Book 1.73
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.89
Resistance 3 (R3) 2.89 2.87 2.87
Resistance 2 (R2) 2.87 2.84 2.86 2.86
Resistance 1 (R1) 2.82 2.82 2.81 2.82 2.86
Pivot Point 2.80 2.80 2.79 2.79 2.80
Support 1 (S1) 2.75 2.77 2.74 2.75 2.70
Support 2 (S2) 2.73 2.75 2.72 2.70
Support 3 (S3) 2.68 2.73 2.69
Support 4 (S4) 2.68